DIN 02538695 — APO-BRIVARACETAM 50 MG
APO-BRIVARACETAM is a tablet of Brivaracetam marketed by APOTEX INC. The full Brivaracetam monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02538695
- Brand name
- APO-BRIVARACETAM
- Active ingredient
- Brivaracetam
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Antiepileptic agent (synaptic vesicle protein 2A ligand)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Brivaracetam products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02538679 | APO-BRIVARACETAM | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02538717 | APO-BRIVARACETAM | 100 MG | TABLET | APOTEX INC | MARKETED |
| 02538687 | APO-BRIVARACETAM | 25 MG | TABLET | APOTEX INC | MARKETED |
| 02538709 | APO-BRIVARACETAM | 75 MG | TABLET | APOTEX INC | MARKETED |
| 02539306 | AURO-BRIVARACETAM | 100 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02539292 | AURO-BRIVARACETAM | 50 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02452936 | BRIVLERA | 10 MG | TABLET | UCB CANADA INC | MARKETED |
| 02452987 | BRIVLERA | 10 MG | SOLUTION | UCB CANADA INC | MARKETED |
| 02452995 | BRIVLERA | 10 MG | SOLUTION | UCB CANADA INC | MARKETED |
| 02452979 | BRIVLERA | 100 MG | TABLET | UCB CANADA INC | MARKETED |
| 02452944 | BRIVLERA | 25 MG | TABLET | UCB CANADA INC | MARKETED |
| 02452952 | BRIVLERA | 50 MG | TABLET | UCB CANADA INC | MARKETED |
| 02452960 | BRIVLERA | 75 MG | TABLET | UCB CANADA INC | MARKETED |